Abstract:The molecular mechanisms by which free fatty acids (FFA) inhibit muscle glucose oxidation is still elusive. We recently showed that C2C12 myotubes treated with palmitate (PAL) presented with greater protein expression levels of PDK4 and transcription factors PPARα and PPARδ and lower p-FOXO/t-FOXO protein ratios when compared to control. This was complemented with the hallmarks of metabolic inflexibility (MI), i.e., reduced rates of glucose uptake, PDC activity and maximal pyruvate-derived ATP production rates (MAPR). However, the relative contribution of these transcription factors to the increase in PDK4 and reduced glucose oxidation could not be established. Therefore, by using a similar myotube model, a series of individual siRNA gene silencing experiments, validated at transcriptional and translation levels, were performed in conjunction with measurements of glucose uptake, PDC activity, MAPR and concentrations of metabolites reflecting PDC flux (lactate and acetylcarnitine). Gene silencing of PPARα, δ and FOXO1 individually reduced PAL-mediated inhibition of PDC activity and increased glucose uptake, albeit by different mechanisms as only PPARδ and FOXO1 silencing markedly reduced PDK4 protein content. Additionally, PPARα and FOXO1 silencing, but not PPARδ, increased MAPR with PAL. PPARδ silencing also decreased FOXO1 protein. Since FOXO1 silencing did not alter PPARδ protein, this suggests that FOXO1 might be a PPARδ downstream target. In summary, this study suggests that the molecular mechanisms by which PAL reduces PDC-mediated glucose-derived pyruvate oxidation in muscle occur primarily through increased PPARδ and FOXO1 mediated increases in PDK4 protein expression and secondarily through PPARα mediated allosteric inhibition of PDC flux. Furthermore, since PPARδ seems to control FOXO1 expression, this may reflect an important role for PPARδ in preventing glucose oxidation under conditions of increased lipid availability.

The transcription factor Foxp1 regulates aerobic glycolysis in adipocytes and myocytes

SCP4 Promotes Gluconeogenesis through FoxO1/3a Dephosphorylation.

Foxp1 controls brown/beige adipocyte differentiation and thermogenesis through regulating β3-AR desensitization

Regulation Of Glucose Homeostasis And Lipid Metabolism By Ppp1r3g-Mediated Hepatic Glycogenesis

Forkhead Box P1 (FOXP1) Transcription Factor Regulates Hepatic Glucose Homeostasis

On the role of FOX transcription factors in adipocyte differentiation and insulin-stimulated glucose uptake

Foxk1 Stimulates Adipogenic Differentiation Via a Peroxisome Proliferator-Activated Receptor Gamma 2-Dependent Mechanism.

Novel Mechanism of Foxo1 Phosphorylation in Glucagon Signaling in Control of Glucose Homeostasis

PPARα, δ and FOXO1 Gene Silencing Overturns Palmitate-Induced Inhibition of Pyruvate Oxidation Differentially in C2C12 Myotubes

Inhibitory regulation of FoxO1 in PPARδ expression drives mitochondria dysfunction and insulin resistance

Nuclear Transcription Factor Foxo1 and Glucose,lipid Metabolism

The forkhead box transcription factor FoxP4 regulates thermogenic programs in adipocytes

A Mutant Allele Encoding DNA Binding–Deficient FoxO1 Differentially Regulates Hepatic Glucose and Lipid Metabolism

An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice

A Novel Mechanism by Foxo1 Phosphorylation Mediates Glucagon Signaling in Control of Glucose Homeostasis

Foxo1-Ser253 Phosphorylation Regulates Glucose Homeostasis in Mice

Phosphorylation of Forkhead Protein FoxO1 at S253 Regulates Glucose Homeostasis in Mice.

FoxO6 Integrates Insulin Signaling with Gluconeogenesis in the Liver.

FoxO1 Plays an Important Role in Regulating Β-Cell Compensation for Insulin Resistance in Male Mice.

FOXO1 induced fatty acid oxidation in hepatic cells by targeting ALDH1L2

The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice